NDC 42571-247 – OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE

Olmesartan Medoxomil 40 mg/1; Amlodipine Besylate 5 mg/1; Hydrochlorothiazide 25 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC42571-247

Product details

Brand name
OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE
Generic name
Olmesartan Medoxomil, Amlodipine besylate and Hydrochlorothiazide
Labeler
Micro Labs Limited
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
ANDA · ANDA207437
Marketed since
March 1, 2026
Listing expires
December 31, 2026
Pharmacologic class
Angiotensin 2 Receptor Blocker; Calcium Channel Blocker; Dihydropyridine Calcium Channel Blocker; Thiazide Diuretic

Active ingredients

Uses, dosage, side effects and warnings for OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE →

Package NDC codes (4)

Package NDCDescriptionSince
42571-247-05500 TABLET, FILM COATED in 1 BOTTLE (42571-247-05)Mar 1, 2026
42571-247-101000 TABLET, FILM COATED in 1 BOTTLE (42571-247-10)Mar 1, 2026
42571-247-3030 TABLET, FILM COATED in 1 BOTTLE (42571-247-30)Mar 1, 2026
42571-247-9090 TABLET, FILM COATED in 1 BOTTLE (42571-247-90)Mar 1, 2026

Other OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE products